KIA
IDXX icon

Kraematon Investment Advisors’s Idexx Laboratories IDXX Stock Holding History

Kraematon Investment Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.7M Sell
5,130
-84
-2% -$47.1K 2.01% 17
2026
Q1 		$2.93M Sell
5,214
-8
-0.2% -$5.13K 2.38% 10
2025
Q4 		$3.53M Sell
5,222
-20
-0.4% -$13.6K 2.81% 8
2025
Q3 		$3.35M Hold
5,242
– – 2.87% 9
2025
Q2 		$2.81M Sell
5,242
-160
-3% -$76.5K 2.65% 10
2025
Q1 		$2.27M Sell
5,402
-60
-1% -$26.1K 2.31% 13
2024
Q4 		$2.26M Sell
5,462
-110
-2% -$48.2K 2.23% 15
2024
Q3 		$2.81M Hold
5,572
– – 2.76% 10
2024
Q2 		$2.71M Sell
5,572
-43
-0.8% -$21.6K 2.76% 9
2024
Q1 		$3.03M Sell
5,615
-135
-2% -$73.8K 3.05% 7
2023
Q4 		$3.19M Sell
5,750
-194
-3% -$91.1K 3.51% 7
2023
Q3 		$2.6M Sell
5,944
-330
-5% -$165K 3.2% 7
2023
Q2 		$3.15M Sell
6,274
-56
-0.9% -$26.8K 3.46% 7
2023
Q1 		$3.17M Sell
6,330
-228
-3% -$109K 3.66% 7
2022
Q4 		$2.68M Buy
6,558
+150
+2% +$58.2K 2.91% 7
2022
Q3 		$2.09M Sell
6,408
-180
-3% -$66.1K 2.69% 8
2022
Q2 		$2.31M Sell
6,588
-54
-0.8% -$22K 2.68% 9
2022
Q1 		$3.63M Sell
6,642
-25
-0.4% -$13.2K 3.46% 6
2021
Q4 		$4.39M Buy
+6,667
New +$4.19M 3.93% 4

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Kraematon Investment Advisors's IDXX Position: Q2 2026 in Review

Kraematon Investment Advisors reduced its Idexx Laboratories (IDXX) stake by 1.6% in Q2 2026, selling an estimated $47.1K and leaving 5,130 shares worth $2.7M. The position accounts for 2.01% of the portfolio, ranked #17.

Kraematon Investment Advisors first reported a position in IDXX in Q4 2021 and has held it in 19 quarters since. The position peaked at $4.39M in Q4 2021. 1,296 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Kraematon Investment Advisors held 5,130 shares of Idexx Laboratories worth $2.7M as of Q2 2026.
  • Kraematon Investment Advisors sold 84 Idexx Laboratories shares in Q2 2026, an estimated $47.1K.
  • Idexx Laboratories made up 2.01% of Kraematon Investment Advisors's portfolio in Q2 2026, its #17 holding.
  • Kraematon Investment Advisors first reported a position in Idexx Laboratories in Q4 2021 and has held it in 19 quarters since.
  • Kraematon Investment Advisors's Idexx Laboratories position peaked at $4.39M in Q4 2021.
  • 1,296 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Kraematon Investment Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.